A detailed history of Bessemer Group Inc transactions in Organon & Co. stock. As of the latest transaction made, Bessemer Group Inc holds 9,182 shares of OGN stock, worth $140,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,182
Previous 5,788 58.64%
Holding current value
$140,300
Previous $120,000 45.83%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$18.65 - $23.03 $63,298 - $78,163
3,394 Added 58.64%
9,182 $175,000
Q2 2024

Aug 13, 2024

BUY
$17.45 - $21.96 $9,178 - $11,550
526 Added 10.0%
5,788 $120,000
Q1 2024

May 13, 2024

BUY
$13.78 - $18.8 $2,893 - $3,948
210 Added 4.16%
5,262 $99,000
Q4 2023

Feb 09, 2024

BUY
$10.95 - $17.32 $2,693 - $4,260
246 Added 5.12%
5,052 $73,000
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $31,686 - $45,400
-1,910 Reduced 28.44%
4,806 $83,000
Q2 2023

Aug 10, 2023

BUY
$19.27 - $24.63 $17,805 - $22,758
924 Added 15.95%
6,716 $141,000
Q1 2023

May 10, 2023

BUY
$21.42 - $32.08 $22,491 - $33,684
1,050 Added 22.14%
5,792 $137,000
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $78,834 - $96,759
-3,382 Reduced 41.63%
4,742 $132,000
Q3 2022

Nov 09, 2022

BUY
$23.4 - $34.25 $16,379 - $23,975
700 Added 9.43%
8,124 $191,000
Q2 2022

Aug 10, 2022

SELL
$31.66 - $38.9 $30,298 - $37,227
-957 Reduced 11.42%
7,424 $250,000
Q1 2022

May 12, 2022

SELL
$30.45 - $39.36 $6,912 - $8,934
-227 Reduced 2.64%
8,381 $294,000
Q4 2021

Jan 27, 2022

BUY
$28.67 - $37.13 $48,050 - $62,229
1,676 Added 24.18%
8,608 $262,000
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $4.37 Million - $5.43 Million
-152,471 Reduced 95.65%
6,932 $226,000
Q2 2021

Aug 06, 2021

BUY
$28.45 - $38.0 $4.54 Million - $6.06 Million
159,403 New
159,403 $4.83 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.